Kintara Therapeutics Inc
For the period ended Jun 30, 2024. Filed Oct 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Oct 7, 2024
HURA$1.63+1.2%Stored close · as of Nov 6, 2026
Opening this filing…